Skip to main content

Table 2 Technical characteristics of plasma exchange therapy 1

From: Efficacy and safety of plasma exchange for Kawasaki disease with coronary artery dilatation

Patient Vascular access Start of PE (day) Duration for PE (days) Total operation time of PE (h)
1 A-V 27 3 19.5
2 7-Fr catheter (FV) 12 3 13.0
3 6-Fr catheter (FV) 9 4 15.0
4 8-Fr catheter (FV) 13 3 5.0
5 6-Fr catheter (FV) 11 3 8.0
6 6-Fr catheter (FV) 10 4 11.5
7 6-Fr catheter (FV) 12 3 8.0
8 6-Fr catheter (FV) 11 4 10.0
9 6-Fr catheter (FV) 21 1 4.5
10 8-Fr catheter (FV) 10 3 7.5
  1. A-V artery-to-vein, FV femoral vein, PE plasma exchange